Acetrizoic Acid
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 561600

CAS#: 85-36-9

Description: Acetrizoic Acid is a high-osmolality, iodine-based radiographic contrast medium.


Price and Availability

Size
Price

1g
USD 230
Size
Price

5g
USD 470
Size
Price

Acetrizoic Acid, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 561600
Name: Acetrizoic Acid
CAS#: 85-36-9
Chemical Formula: C9H6I3NO3
Exact Mass: 556.7482
Molecular Weight: 556.86
Elemental Analysis: C, 19.41; H, 1.09; I, 68.37; N, 2.52; O, 8.62


Synonym: Acetrizoic Acid; Opacaron; Urokon;

IUPAC/Chemical Name: 3-Acetamido-2,4,6-triiodobenzoic acid

InChi Key: GNOGSFBXBWBTIG-UHFFFAOYSA-N

InChi Code: InChI=1S/C9H6I3NO3/c1-3(14)13-8-5(11)2-4(10)6(7(8)12)9(15)16/h2H,1H3,(H,13,14)(H,15,16)

SMILES Code: O=C(O)C1=C(I)C=C(I)C(NC(C)=O)=C1I


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

Harmonized System Code:
293490


References

1: The MICAD Research Team. N-(2,3-Dihydroxypropyl)-N´-(2-hydroxyethyl)-5-[N-(2,3-dihydroxypropyl)acetamido]- 2,4,6-triiodoisophthalamide. 2006 Jul 12 [updated 2006 Aug 9]. Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013. Available from http://www.ncbi.nlm.nih.gov/books/NBK26369/ PubMed PMID: 20641973.

2: Cheng KT. N,N´-Bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl-3-methoxypropyl)-acetamidol]-2 ,4,6-triiodoisophthalamide. 2006 Mar 6 [updated 2008 Mar 4]. Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013. Available from http://www.ncbi.nlm.nih.gov/books/NBK26367/ PubMed PMID: 20641971.

3: Cheng KT. N,N´-Bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)-glycolamidol]-2,4,6-triiodois ophthalamide. 2006 Feb 7 [updated 2008 Feb 7]. Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013. Available from http://www.ncbi.nlm.nih.gov/books/NBK26366/ PubMed PMID: 20641970.

4: Cheng KT. 5-[3-Hydroxy-2-hydroxymethyl-propionamido)-N,N´-dimethyl-N,N´-bis-(2,3-dihydroxyp ropyl)-2,4,6-triiodoisophthalamide. 2006 May 16 [updated 2008 Apr 21]. Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013. Available from http://www.ncbi.nlm.nih.gov/books/NBK25584/ PubMed PMID: 20641966.

5: Sergeev PV, Sviridov NK. [Effect of contrast media on the cardiovascular system (review of the literature)]. Farmakol Toksikol. 1977 Jul-Aug;40(4):498-503. Review. Russian. PubMed PMID: 332518.

6: Classen JN, Martin RE, Thompson NO. Complications of colon and rectum following diagnosis. Prophylaxis and therapy. Acta Chir Belg. 1977 May-Jun;76(3):235-47. Review. PubMed PMID: 331814.

7: Lazecki L. [Nephrotropic contrast media]. Pol Przegl Radiol Med Nukl. 1975 Mar-Apr;39(2):239-50. Review. Polish. PubMed PMID: 1096096.

8: Saxton HM. Review article: urography. Br J Radiol. 1969 May;42(497):321-46. Review. PubMed PMID: 4914357.